Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Identifying Myeloid Mutations By NGS in Patients with Unexplained Erythrocytosis

Eri Kawata, MDPhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MDMSc, Michael Levy, PhD, Stephanie Santos, Hanxin Lin, PhD, Chris Howlett, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2020) 136 (Supplement 1): 47.

https://doi.org/10.1182/blood-2020-138654

Published: 2020

Journal Articles

Reducing Cytogenetic Testing in the Era of Next Generation Sequencing (NGS); Are We Choosing Wisely?

Eri Kawata, MDPhD, Benjamin Hedley, PhD, Benjamin Chin-Yee, MD, Anargyros Xenocostas, MD FRCPC, Alejandro Lazo-Langner, MDMSc, Cyrus C. Hsia, MDBSc,FRCPC, Kang Howson-Jan, MD FRCPC, Ping Yang, PhD DABMGG, Michael Levy, PhD, Stephanie Santos, Chris Howlett, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-138667

Published: 2020

Journal Articles

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Alejandro Lazo-Langner, MD MSc, Kang Howson-Jan, MD FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Benjamin Hedley, PhD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3438.

https://doi.org/10.1182/blood-2019-128507

Published: 2019

Journal Articles

The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome

Eri Kawata, MD PhD, Anargyros Xenocostas, MD FRCPC, Cyrus C. Hsia, MDBSc,FRCPC, Uday Deotare, MBBS, MD DM, Lalit Saini, MD, Ping Yang, PhD DABMGG, Michael Levy, PhD, Hanxin Lin, PhD, Bekim Sadikovic, PhD DABMGG, FACMG, Ian Chin-Yee, MD FRCPC

Blood (2019) 134 (Supplement_1): 3375.

https://doi.org/10.1182/blood-2019-126893

Published: 2019

Journal Articles

Blood Donation May Not Reduce Risk of Testosterone-Induced Polycythemia

Benjamin Hull Chin-Yee, BSc, MA, Alejandro Lazo-Langner, MD, Terrie Foster, RN, BScN, Cyrus C. Hsia, MD BSc, FRCPC, Ian Chin-Yee, MD FRCPC

Blood (2016) 128 (22): 5032.

https://doi.org/10.1182/blood.V128.22.5032.5032

Published: 2016

Journal Articles

Does Cell Size Matter?: Utilizing Mean Cell Volume in Hospitalized Patients As a Screen to Determine Common Causes of Anemia Including Iron Deficiency Anemia, Vitamin B12 and Folate Deficiency

Manika Gupta, MD, Kathleen Copley, MLT, Michael Keeney, ART,FIMLS(D), Ian Chin-Yee, MD FRCPC

Blood (2016) 128 (22): 2338.

https://doi.org/10.1182/blood.V128.22.2338.2338

Published: 2016

Journal Articles

Transfusion of Fresh but Not Stored Blood Reduces Infarct Size and Improves Cardiac Function Following Acute Myocardial Infarction In Anemic Rats

Anargyros Xenocostas, MD, FRCPC, Houxiang Hu, MD, Nicolas J Chin-Yee, Ian Chin-Yee, MD, FRCPC, Qingping Feng, MD, PhD

Blood (2010) 116 (21): 661.

https://doi.org/10.1182/blood.V116.21.661.661

Published: 2010

Journal Articles

Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.

Leonard A. Minuk, MD, FRCPC, Ian Chin-Yee, MD, FRCPC, Kang Howson-Jan, MD, FRCPC, Reinhard Lohmann, MD, FRCPC, Alejandro Lazo-Langner, MD MSC, Vinai C. Bhagirath, MD, Joy Mangel, MD, FRCPC

Blood (2009) 114 (22): 2502.

https://doi.org/10.1182/blood.V114.22.2502.2502

Published: 2009

Journal Articles

Erythropoietin Is Equally Effective as Blood Transfusion at Reducing Infarct Size in Anemic Rats.

Anargyros Xenocostas, MD, FRCPC, Houxiang Hu, MD, Nicolas J Chin-Yee, Xiangru Lu, MD, Ian Chin-Yee, MD, FRCPC, Qingping Feng, MD, PhD

Blood (2009) 114 (22): 639.

https://doi.org/10.1182/blood.V114.22.639.639

Published: 2009

Journal Articles

A Retrospective Case Review of Adverse Drug Reactions Using Intravenous Iron in Non-Hemodialysis Patients.

Cyrus C. Hsia, MD, Katrina Ormond, RN, Anagyros Xenocostas, MD, FRCPC, Ian Chin-Yee, MD, FRCPC

Blood (2004) 104 (11): 3685.

https://doi.org/10.1182/blood.V104.11.3685.3685

Published: 2004

NARROW

Identifying Myeloid Mutations By NGS in Patients with Unexplained Erythrocytosis

Reducing Cytogenetic Testing in the Era of Next Generation Sequencing (NGS); Are We Choosing Wisely?

Reevaluating the Role of Cytogenetic Testing in Patients with Suspected Myelodysplastic Syndrome in the Era of Next Generation Sequencing

The Clinical Application of Oncomine Myeloid Next Generation Sequencing (NGS): Comparison of Cytogenetics and NGS in Patients with Suspected Myelodysplastic Syndrome

Blood Donation May Not Reduce Risk of Testosterone-Induced Polycythemia

Does Cell Size Matter?: Utilizing Mean Cell Volume in Hospitalized Patients As a Screen to Determine Common Causes of Anemia Including Iron Deficiency Anemia, Vitamin B12 and Folate Deficiency

Transfusion of Fresh but Not Stored Blood Reduces Infarct Size and Improves Cardiac Function Following Acute Myocardial Infarction In Anemic Rats

Treatment of Hodgkin Lymphoma without G-CSF Does Not Increase the Risk of Febrile Neutropenia.

Erythropoietin Is Equally Effective as Blood Transfusion at Reducing Infarct Size in Anemic Rats.

A Retrospective Case Review of Adverse Drug Reactions Using Intravenous Iron in Non-Hemodialysis Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only